Cargando...
PCSK9 inhibition to reduce cardiovascular disease risk: recent findings from the biology of PCSK9
PURPOSE OF REVIEW: Review novel insights into the biology of proprotein convertase subtilisin/kexin 9 (PCSK9) that may explain the extreme efficiency of PCSK9 inhibition and the unexpected metabolic effects resulting from PCSK9 monoclonal antibody therapy, and may identify additional patients as tar...
Guardado en:
| Publicado en: | Curr Opin Endocrinol Diabetes Obes |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4384821/ https://ncbi.nlm.nih.gov/pubmed/25692926 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MED.0000000000000137 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|